SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Lin D., Li L., Dick D., Shope R.E., Feldmann H., Barrett A.D., Holbrook M.R. (2003) Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus. Virology 313: 8190.
  • 2
    Holbrook M.R., Aronson J.F., Campbell G.A., Jones S., Feldmann H., Barrett A.D. (2005) An animal model for the tickborne flavivirus—Omsk hemorrhagic fever virus. J Infect Dis 191: 1008.
  • 3
    Holbrook M.R., Shope R.E., Barrett A.D. (2004) Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses. J Clin Microbiol 42: 410110.
  • 4
    Volk D.E., Chavez L., Beasley D.W., Barrett A.D., Holbrook M.R., Gorenstein D.G. (2006) Structure of the envelope protein domain III of Omsk hemorrhagic fever virus. Virology 351: 18895.
  • 5
    Yoshii K., Holbrook M.R. (2009) Sub-genomic replicon and virus-like particles of Omsk hemorrhagic fever virus. Arch Virol 154: 57380.
  • 6
    Gunther G., Haglund M. (2005) Tick-borne encephalopathies: epidemiology, diagnosis, treatment and prevention. CNS Drugs 19: 100932.
  • 7
    Pogodina V.V. (2005) Monitoring of tick-borne encephalitis virus populations and etiological structure of morbidity over 60 years. Vopr Virusol 50: 713.
  • 8
    Golovljova I., Vene S., Sjolander K.B., Vasilenko V., Plyusnin A., Lundkvist A. (2004) Characterization of tick-borne encephalitis virus from Estonia. J Med Virol 74: 5808.
  • 9
    Heinz F.X., Kunz C. (2004) Tick-borne encephalitis and the impact of vaccination. Arch Virol Suppl 18: 2015.
  • 10
    Ecker M., Allison S.L., Meixner T., Heinz F.X. (1999) Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80 (Pt 1): 17985.
  • 11
    Fritz R., Orlinger K.K., Hofmeister Y., Janecki K., Traweger A., Perez-Burgos L., Barrett P.N., Kreil T.R. (2012) Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes. Vaccine 30: 11659.
  • 12
    Heinz F.X., Kunz C. (1981) Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol 57: 26374.
  • 13
    Chiba N., Iwasaki T., Mizutani T., Kariwa H., Kurata T., Takashima I. (1999) Pathogenicity of tick-borne encephalitis virus isolated in Hokkaido, Japan in mouse model. Vaccine 17: 77987.
  • 14
    Amicizia D., Domnich A., Panatto D., Lai P.L., Luisa Cristina M., Avio U., Gasparini R. (2013) Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines. Hum Vaccin Immunother 9: 116371.
  • 15
    Banzhoff A., Broker M., Zent O. (2008) Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas. Travel Med Infect Dis 6: 33141.
  • 16
    Broker M., Gniel D. (2003) New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad. Travel Med Infect Dis 1: 1814.
  • 17
    Donoso Mantke O., Schadler R., Niedrig M. (2008) A survey on cases of tick-borne encephalitis in European countries. Euro Surveill 13: pii = 18848. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18848.
  • 18
    Ruzek D., Yakimenko V.V., Karan L.S., Tkachev S.E. (2010) Omsk haemorrhagic fever. Lancet 376: 210413.
  • 19
    Westaway E.G., Brinton M.A., Gaidamovich S., Horzinek M.C., Igarashi A., Kaariainen L., Lvov D.K., Porterfield J.S., Russell P.K., Trent D.W. (1985) Flaviviridae. Intervirology 24: 18392.
  • 20
    Yoshii K., Hayasaka D., Goto A., Obara M., Araki K., Yoshimatsu K., Arikawa J., Ivanov L., Mizutani T., Kariwa H., Takashima I. (2003) Enzyme-linked immunosorbent assay using recombinant antigens expressed in mammalian cells for serodiagnosis of tick-borne encephalitis. J Virol Methods 108: 1719.
  • 21
    Leonova G.N., Pavlenko E.V. (2009) Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human. Vaccine 27: 2899904.
  • 22
    Beran J., Douda P., Gniel D., Zent O. (2004) Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule. Int J Med Microbiol 293 (Suppl 37): 1303.
  • 23
    Zent O., Schwarz T.F., Plentz A., Banzhoff A., Jilg W. (2004) TBE booster immunization in adults–first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Int J Med Microbiol 293 (Suppl 37): 1348.
  • 24
    Loew-Baselli A., Konior R., Pavlova B.G., Fritsch S., Poellabauer E., Maritsch F., Harmacek P., Krammer M., Barrett P.N., Ehrlich H.J. (2006) Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. Vaccine 24: 525663.
  • 25
    Leonova G.N., Ternovoi V.A., Pavlenko E.V., Maistrovskaya O.S., Protopopova E.V., Loktev V.B. (2007) Evaluation of vaccine Encepur adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus. Vaccine 25: 895901.
  • 26
    Chiba N., Osada M., Komoro K., Mizutani T., Kariwa H., Takashima I. (1999) Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization. Vaccine 17: 15329.
  • 27
    Khoretonenko M.V., Vorovitch M.F., Zakharova L.G., Pashvykina G.V., Ovsyannikova N.V., Stephenson J.R., Timofeev A.V., Altstein A.D., Shneider A.M. (2003) Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice. Immunol Lett 90: 1613.
  • 28
    De Paula S.O., Lima D.M., De Oliveira Franca R.F., Gomes-Ruiz A.C., Da Fonseca B.A. (2008) A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge. Arch Virol 153: 221523.
  • 29
    Konishi E., Pincus S., Paoletti E., Shope R.E., Burrage T., Mason P.W. (1992) Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology 188: 71420.
  • 30
    Ocazionez Jimenez R., Lopes Da Fonseca B.A. (2000) Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice. Vaccine 19: 64854.
  • 31
    Konishi E., Yamaoka M., Khin Sane W., Kurane I., Mason P.W. (1998) Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J Virol 72: 492530.
  • 32
    Allison S.L., Stiasny K., Stadler K., Mandl C.W., Heinz F.X. (1999) Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol 73: 560512.
  • 33
    Chavez J.H., Silva J.R., Amarilla A.A., Moraes Figueiredo L.T. (2010) Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. Biologicals 38: 6138.
  • 34
    Oliphant T., Nybakken G.E., Engle M., Xu Q., Nelson C.A., Sukupolvi-Petty S., Marri A., Lachmi B.E., Olshevsky U., Fremont D.H., Pierson T.C., Diamond M.S. (2006) Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol 80: 1214959.
  • 35
    Sukupolvi-Petty S., Austin S.K., Purtha W.E., Oliphant T., Nybakken G.E., Schlesinger J.J., Roehrig J.T., Gromowski G.D., Barrett A.D., Fremont D.H., Diamond M.S. (2007) Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol 81: 1281626.
  • 36
    Oliphant T., Nybakken G.E., Austin S.K., Xu Q., Bramson J., Loeb M., Throsby M., Fremont D.H., Pierson T.C., Diamond M.S. (2007) Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol 81: 1182839.
  • 37
    Lai C.Y., Tsai W.Y., Lin S.R., Kao C.L., Hu H.P., King C.C., Wu H.C., Chang G.J., Wang W.K. (2008) Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 82: 663143.
  • 38
    Yoshii K., Igarashi M., Ito K., Kariwa H., Holbrook M.R., Takashima I. (2011) Construction of an infectious cDNA clone for Omsk hemorrhagic fever virus, and characterization of mutations in NS2A and NS5. Virus Res 155: 618.
  • 39
    Goncalvez A.P., Purcell R.H., Lai C.J. (2004) Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. J Virol 78: 1291928.
  • 40
    Chiou S.S., Fan Y.C., Crill W.D., Chang R.Y., Chang G.J. (2012) Mutation analysis of the cross-reactive epitopes of Japanese encephalitis virus envelope glycoprotein. J Gen Virol 93: 118592.
  • 41
    Li L., Rollin P.E., Nichol S.T., Shope R.E., Barrett A.D., Holbrook M.R. (2004) Molecular determinants of antigenicity of two subtypes of the tick-borne flavivirus Omsk haemorrhagic fever virus. J Gen Virol 85: 161924.
  • 42
    Tigabu B., Juelich T., Bertrand J., Holbrook M.R. (2009) Clinical evaluation of highly pathogenic tick-borne flavivirus infection in the mouse model. J Med Virol 81: 12619.
  • 43
    Muller D.A., Young P.R. (2013) The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res 98: 192208.
  • 44
    Lin C.F., Wan S.W., Chen M.C., Lin S.C., Cheng C.C., Chiu S.C., Hsiao Y.L., Lei H.Y., Liu H.S., Yeh T.M., Lin Y.S. (2008) Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model. Lab Invest 88: 107989.
  • 45
    Falconar A.K. (1997) The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 142: 897916.
  • 46
    Vogt M.R., Dowd K.A., Engle M., Tesh R.B., Johnson S., Pierson T.C., Diamond M.S. (2011) Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms. J Virol 85: 11,56780.
  • 47
    Plentz A., Jilg W., Schwarz T.F., Kuhr H.B., Zent O. (2009) Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults. Vaccine 27: 8536.
  • 48
    Loew-Baselli A., Poellabauer E.M., Pavlova B.G., Fritsch S., Koska M., Bobrovsky R., Konior R., Ehrlich H.J. (2009) Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged18–67 years. Hum Vaccine 5: 5516.
  • 49
    Hayasaka D., Goto A., Yoshii K., Mizutani T., Kariwa H., Takashima I. (2001) Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains. Vaccine 19: 47749.
  • 50
    Orlinger K.K., Hofmeister Y., Fritz R., Holzer G.W., Falkner F.G., Unger B., Loew-Baselli A., Poellabauer E.M., Ehrlich H.J., Barrett P.N., Kreil T.R. (2011) A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans. J Infect Dis 203: 155664.
  • 51
    Kuno G., Gubler D.J., Oliver A. (1993) Use of 'original antigenic sin' theory to determine the serotypes of previous dengue infections. Trans R Soc Trop Med Hyg 87: 1035.
  • 52
    Midgley C.M., Bajwa-Joseph M., Vasanawathana S., Limpitikul W., Wills B., Flanagan A., Waiyaiya E., Tran H.B., Cowper A.E., Chotiyarnwong P., Grimes J.M., Yoksan S., Malasit P., Simmons C.P., Mongkolsapaya J., Screaton G.R. (2011) An in-depth analysis of original antigenic sin in dengue virus infection. J Virol 85: 41021.
  • 53
    Halstead S.B., Rojanasuphot S., Sangkawibha N. (1983) Original antigenic sin in dengue. Am J Trop Med Hyg 32: 1546.
  • 54
    Gibbons R.V. (2010) Dengue conundrums. Int J Antimicrob Agents 36 (Suppl 1): S369.